Sl Science(NASDAQ) SLBT

SL Science Holding Ltd is a biotechnology company focused on strategic business combinations with other firms. Founded in 2023 and headquartered in New York, the company aims to leverage various transactional structures to achieve its objectives.

Products and Services

• Strategic business combinations through mergers and acquisitions
• Asset exchanges and direct stock purchases
• Corporate reorganizations and recapitalizations

Growth Outlook

• Market capitalization stands at approximately $33.8 million
• Recent quarterly cash and short-term investments totaled $1.26 million
• Current ratio of 3.05 indicates strong liquidity position

Financial Highlights

• Trailing twelve months revenue of $4.3 million
• Net income margin shows a significant loss of 1.74%
• Cash flow coverage ratios indicate a negative trend

SL Science Holding Ltd operates in the dynamic biotechnology sector, focusing on strategic mergers and acquisitions. The company has established a solid foundation with a market capitalization of approximately $33.8 million, reflecting its potential for growth. The recent quarterly financials indicate a liquidity position that is favorable, with cash and short-term investments amounting to $1.26 million. Despite facing challenges, such as a net income margin reflecting a loss of 1.74%, the company maintains a current ratio of 3.05, suggesting it can cover its short-term liabilities effectively. The trailing twelve months revenue of $4.3 million highlights the company's operational scale, while cash flow coverage ratios indicate areas for improvement. Overall, SL Science Holding Ltd presents an intriguing opportunity within the biotechnology industry, with a focus on strategic growth through business combinations.